These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11920976)

  • 1. Long-term impact of treatment in women diagnosed with bulimia nervosa.
    Keel PK; Mitchell JE; Davis TL; Crow SJ
    Int J Eat Disord; 2002 Mar; 31(2):151-8. PubMed ID: 11920976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of outcome in bulimia nervosa and the long-term effects of three psychological treatments.
    Fairburn CG; Norman PA; Welch SL; O'Connor ME; Doll HA; Peveler RC
    Arch Gen Psychiatry; 1995 Apr; 52(4):304-12. PubMed ID: 7702447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotherapy and bulimia nervosa. Longer-term effects of interpersonal psychotherapy, behavior therapy, and cognitive behavior therapy.
    Fairburn CG; Jones R; Peveler RC; Hope RA; O'Connor M
    Arch Gen Psychiatry; 1993 Jun; 50(6):419-28. PubMed ID: 8498876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.
    Barlow DH; Gorman JM; Shear MK; Woods SW
    JAMA; 2000 May; 283(19):2529-36. PubMed ID: 10815116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of exposure with response prevention in the cognitive-behavioural therapy for bulimia nervosa.
    Bulik CM; Sullivan PF; Carter FA; McIntosh VV; Joyce PR
    Psychol Med; 1998 May; 28(3):611-23. PubMed ID: 9626717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication and psychotherapy in the treatment of bulimia nervosa.
    Walsh BT; Wilson GT; Loeb KL; Devlin MJ; Pike KM; Roose SP; Fleiss J; Waternaux C
    Am J Psychiatry; 1997 Apr; 154(4):523-31. PubMed ID: 9090340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social adjustment over 10 years following diagnosis with bulimia nervosa.
    Keel PK; Mitchell JE; Miller KB; Davis TL; Crow SJ
    Int J Eat Disord; 2000 Jan; 27(1):21-8. PubMed ID: 10590445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa.
    Mitchell JE; Pyle RL; Eckert ED; Hatsukami D; Pomeroy C; Zimmerman R
    Arch Gen Psychiatry; 1990 Feb; 47(2):149-57. PubMed ID: 2405806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa.
    Mitchell JE; Raymond N; Specker S
    Int J Eat Disord; 1993 Nov; 14(3):229-47. PubMed ID: 8275060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa.
    Agras WS; Walsh T; Fairburn CG; Wilson GT; Kraemer HC
    Arch Gen Psychiatry; 2000 May; 57(5):459-66. PubMed ID: 10807486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between depression and body dissatisfaction in women diagnosed with bulimia nervosa.
    Keel PK; Mitchell JE; Davis TL; Crow SJ
    Int J Eat Disord; 2001 Jul; 30(1):48-56. PubMed ID: 11439408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cognitive-behavioral therapy for bulimia nervosa on temperament and character as measured by the temperament and character inventory.
    Anderson CB; Joyce PR; Carter FA; McIntosh VV; Bulik CM
    Compr Psychiatry; 2002; 43(3):182-8. PubMed ID: 11994835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined cognitive-behavioral, psychopharmacological and nutritional therapy in bulimia nervosa.
    Brambilla F; Draisci A; Peirone A; Brunetta M
    Neuropsychobiology; 1995; 32(2):68-71. PubMed ID: 7477802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequencing of cognitive-behavioral treatments for bulimia nervosa.
    Davis R; McVey G; Heinmaa M; Rockert W; Kennedy S
    Int J Eat Disord; 1999 May; 25(4):361-74. PubMed ID: 10202647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological versus pharmacological treatments of bulimia nervosa: predictors and processes of change.
    Wilson GT; Loeb KL; Walsh BT; Labouvie E; Petkova E; Liu X; Waternaux C
    J Consult Clin Psychol; 1999 Aug; 67(4):451-9. PubMed ID: 10450615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of bulimia nervosa and binge eating disorder: longer-term outcomes.
    Agras WS
    Psychopharmacol Bull; 1997; 33(3):433-6. PubMed ID: 9550889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial and pharmacological treatment of eating disorders: a review of research findings.
    Peterson CB; Mitchell JE
    J Clin Psychol; 1999 Jun; 55(6):685-97. PubMed ID: 10445860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotherapy for bulimia nervosa and binging.
    Hay PJ; Bacaltchuk J
    Cochrane Database Syst Rev; 2000; (2):CD000562. PubMed ID: 10796725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cue reactivity as a predictor of outcome with bulimia nervosa.
    Carter FA; Bulik CM; McIntosh VV; Joyce PR
    Int J Eat Disord; 2002 Apr; 31(3):240-50. PubMed ID: 11920985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postremission predictors of relapse in women with eating disorders.
    Keel PK; Dorer DJ; Franko DL; Jackson SC; Herzog DB
    Am J Psychiatry; 2005 Dec; 162(12):2263-8. PubMed ID: 16330589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.